175 related articles for article (PubMed ID: 15326249)
1. Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis.
Lane M; McBride J; Archer J
Neurology; 2004 Aug; 63(4):713-4. PubMed ID: 15326249
[TBL] [Abstract][Full Text] [Related]
2. Cryptococcal meningitis in an immunocompetent patient.
Murphy LS; Lacy AJ; Smith AT; Shah KS
Am J Emerg Med; 2020 Nov; 38(11):2492.e1-2492.e3. PubMed ID: 32534877
[TBL] [Abstract][Full Text] [Related]
3. [Cryptococcal meningitis in a patient with a ventriculoperitoneal shunt and monitoring for pulmonary sarcoidosis].
Baallal H; El Asri AC; Eljebbouri B; Akhaddar A; Gazzaz M; El Mostarchid B; Boucetta M
Neurochirurgie; 2013 Feb; 59(1):47-9. PubMed ID: 23395187
[TBL] [Abstract][Full Text] [Related]
4. Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing.
Soares BM; Santos DA; Kohler LM; da Costa César G; de Carvalho IR; dos Anjos Martins M; Cisalpino PS
Rev Iberoam Micol; 2008 Dec; 25(4):242-5. PubMed ID: 19071894
[TBL] [Abstract][Full Text] [Related]
5. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Sloan D; Dlamini S; Paul N; Dedicoat M
Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
[TBL] [Abstract][Full Text] [Related]
7. Undiagnosed Cryptococcus gattii meningitis leading to subsequent ventriculoperitoneal shunt infection in a patient with symptoms of normal pressure hydrocephalus: case report and literature review.
Dhitinanmuang W; Chongtrakool P; Jitmuang A
BMC Infect Dis; 2018 Jun; 18(1):257. PubMed ID: 29866070
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting.
Park MK; Hospenthal DR; Bennett JE
Clin Infect Dis; 1999 Mar; 28(3):629-33. PubMed ID: 10194090
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcal meningitis in immunocompetent children.
Yuanjie Z; Jianghan C; Nan X; Xiaojun W; Hai W; Wanqing L; Julin G
Mycoses; 2012 Mar; 55(2):168-71. PubMed ID: 21762212
[TBL] [Abstract][Full Text] [Related]
10. Cryptococcal meningitis in an immunocompetent adolescent.
Ma AL; Fong NC; Leung CW
Ann Trop Paediatr; 2008 Sep; 28(3):231-4. PubMed ID: 18727853
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y
Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606
[TBL] [Abstract][Full Text] [Related]
12. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.
Mitchell DH; Sorrell TC; Allworth AM; Heath CH; McGregor AR; Papanaoum K; Richards MJ; Gottlieb T
Clin Infect Dis; 1995 Mar; 20(3):611-6. PubMed ID: 7756484
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
Jaruratanasirikul S
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
[TBL] [Abstract][Full Text] [Related]
14. The role of an Ommaya reservoir in the management of children with cryptococcal meningitis.
Jiang PF; Yu HM; Zhou BL; Gao F; Shen SX; Xia ZZ; Shui QX
Clin Neurol Neurosurg; 2010 Feb; 112(2):157-9. PubMed ID: 19910108
[TBL] [Abstract][Full Text] [Related]
15. Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.
Hossain MA; Mukherjee PK; Reyes G; Long L; Ghannoum MA
J Chemother; 2002 Aug; 14(4):351-60. PubMed ID: 12420852
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
[No Abstract] [Full Text] [Related]
17. Antifungal therapy for treatment of cryptococcal meningitis.
Yao Z; Liao W; Wen H
Chin Med J (Engl); 2000 Feb; 113(2):178-80. PubMed ID: 11775548
[TBL] [Abstract][Full Text] [Related]
18. Current approach to the acute management of cryptococcal infections.
Powderly WG
J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
[No Abstract] [Full Text] [Related]
19. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis.
Woodworth GF; McGirt MJ; Williams MA; Rigamonti D
Surg Neurol; 2005 Jun; 63(6):529-31; discussion 531-2. PubMed ID: 15936373
[TBL] [Abstract][Full Text] [Related]
20. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
